No Result
View All Result
  • Private Data
  • Membership options
  • Login
  • COUNTRY
    • ITALY
    • IBERIA
    • FRANCE
    • UK&IRELAND
    • BENELUX
    • DACH
    • SCANDINAVIA&BALTICS
  • PRIVATE EQUITY
  • VENTURE CAPITAL
  • PRIVATE DEBT
  • DISTRESSED ASSETS
  • REAL ESTATE
  • FINTECH
  • GREEN
  • PREMIUM
    • ItaHubHOT
      • ItaHub Legal
      • ItaHub Tax
      • ItaHub Trend
    • REPORT
    • INSIGHT VIEW
    • Private Data
Subscribe
  • COUNTRY
    • ITALY
    • IBERIA
    • FRANCE
    • UK&IRELAND
    • BENELUX
    • DACH
    • SCANDINAVIA&BALTICS
  • PRIVATE EQUITY
  • VENTURE CAPITAL
  • PRIVATE DEBT
  • DISTRESSED ASSETS
  • REAL ESTATE
  • FINTECH
  • GREEN
  • PREMIUM
    • ItaHubHOT
      • ItaHub Legal
      • ItaHub Tax
      • ItaHub Trend
    • REPORT
    • INSIGHT VIEW
    • Private Data
Home COUNTRY FRANCE

PRODUCTLIFE GROUP ACQUIRES COMMERCIAL EYES, EXPANDING ITS FOOTPRINT IN THE APAC REGION

Cisionby Cision
February 1, 2024
Reading Time: 3 mins read
in FRANCE, PRIVATE EQUITY
Share on FacebookShare on Twitter

PARIS, Jan. 31, 2024 /PRNewswire/ — ProductLife Group (PLG), the specialised global provider of regulatory, scientific, vigilance, quality and digital transformation consulting services for the life sciences industries, announces the acquisition of Commercial Eyes, Australia’s leading pharmaceutical and medical device commercialisation company, specialising in regulatory affairs, pharmacovigilance, medical information, quality assurance, market access, market research and patient programs.

This partnership unlocks numerous synergistic opportunities for both organisations and their clients. ProductLife Group’s global presence and expertise, combined with the regional knowledge and capabilities of Commercial Eyes, will enable ProductLife Group to deliver enhanced services and solutions to its clients. The expanded portfolio of offerings will empower clients to navigate complex frameworks with confidence, ensuring successful market and patient access of new healthcare solutions in full compliance with regulatory requirements and in line with payers expectations.

Andrew Carter, Founder & Managing Director of Commercial Eyes : “Joining PLG is a major strategic move for Commercial Eyes, our people and our clients. We will leverage the platform we have created over the last 22 years to expand our footprint globally. This will create significant professional development opportunities for our team members and enable us to better support our clients with global coverage of end-to-end life sciences consulting services.”

Xavier Duburcq, CEO of PLG, highlighted: ” This merger not only enables us to broaden our geographical footprint and expand our offerings to global markets but also empowers us to better serve our clients throughout their market and patient access strategy. The acquisition of Commercial Eyes marks an exciting new chapter in our journey. Together, we possess the collective strength, expertise, and passion to drive positive change and shape the future of the life sciences industry.

Our two companies share similar values: pioneering the way for innovation, client satisfaction, team spirit and a unique sense of purpose for life sciences. This common set of values forms a solid foundation for the seamless integration of the two organisations.”

About ProductLife Group: 

ProductLife Group’s mission is to support patient access to safe and effective healthcare solutions by delivering worldwide consulting and outsourcing services through the entire product life.

Combining local expertise with global reach spanning more than 150 countries, PLG is the Life Sciences Industries reference strategic partner for the development, market introduction and life cycle management of product portfolios, and the related business and digital transformation.

With a goal of continuously improving the value delivered to teams and clients, PLG is committed to long-term partnership, innovation, flexibility, and cost efficiency.

For more information, visit https://productlifegroup.com/
Contact:
Fabrice Galzin
ProductLife Group Head of Marketing
Phone: + 33 (0) 672 349 606
fgalzin@productlife-group.com 

About Commercial Eyes:
Commercial Eyes is a healthcare and life sciences consulting firm, specialising in pre and post registration services, comprising amongst others Access, Research & Intelligence (ARI), Regulatory, Quality and Compliance (RQC), Patient Safety & Risk Management (PS), Medical Information (MI) and Patient Programs (PP). Commercial Eyes is headquartered in Melbourne (Australia) with a presence in New Zealand, where the company is known as one of the largest providers of commercialisation services to the Pharma and MedTech sector. For over 22 years Commercial Eyes has delivered high quality, customer-focused results in the Australian and New Zealand regulated therapeutics and healthcare industry.

Commercial Eyes has grown to become a leading pharmaceutical and medical device commercialisation business. With a team of over 100 people, the company has assisted more than 800 clients representing the full spectrum of health technology companies.

For more information, visit https://commercialeyes.com.au/ 

Contact:
Andrew Carter
Chief Executive Officer
andrew.carter@commercialeyes.com.au 

Cision View original content:https://www.prnewswire.co.uk/news-releases/productlife-group-acquires-commercial-eyes-expanding-its-footprint-in-the-apac-region-302049928.html

Read the orginal article: undefined

Gateways to Italy

Gateways to Italy – Offer your services to funds and investors willing to explore opportunities in Italy. Become a partner!

Gateways to Italy – Offer your services to funds and investors willing to explore opportunities in Italy. Become a partner!

by Partner
June 6, 2023

Sign up to our newsletter

SIGN UP

Related Posts

FINTECH

G42 and Mistral AI unite to build next-gen AI platforms and infrastructures

May 21, 2025
FRANCE

SFR and Bouygues Telecom put French tower JV up for sale – report

May 21, 2025
FRANCE

Prologis to develop four data center sites in Paris, France

May 21, 2025

ItaHub

Crypto-assets supervision rules in Italy, Banca d’Italia will supervise payment systems and Consob on market abuse

Crypto-assets supervision rules in Italy, Banca d’Italia will supervise payment systems and Consob on market abuse

November 4, 2024
Italy’s SMEs export toward 260 bn euros in 2025

Italy’s SMEs export toward 260 bn euros in 2025

September 9, 2024
With two months to go before the NPL Directive, in Italy the securitization rebus is still to be unraveled

With two months to go before the NPL Directive, in Italy the securitization rebus is still to be unraveled

April 23, 2024
EU’s AI Act, like previous rules on technology,  looks more defensive than investment-oriented

EU’s AI Act, like previous rules on technology, looks more defensive than investment-oriented

January 9, 2024

Co-sponsor

Premium

Funds vying for management consulting firm BIP, a CVC portfolio company. All deals in the sector

Funds vying for management consulting firm BIP, a CVC portfolio company. All deals in the sector

March 6, 2025
Private equity, Italy 2024 closes with 588 deals as for investments and divestments from 549 in 2023. Here is the new BeBeez’s report

Private equity, Italy 2024 closes with 588 deals as for investments and divestments from 549 in 2023. Here is the new BeBeez’s report

February 10, 2025
Crypto-assets supervision rules in Italy, Banca d’Italia will supervise payment systems and Consob on market abuse

Crypto-assets supervision rules in Italy, Banca d’Italia will supervise payment systems and Consob on market abuse

November 4, 2024
Venture capital investments top €1.3bn in 208 rounds as of Sep30  in Italy. They were €1.5 in all 2023. The new BeBeez Report

Venture capital investments top €1.3bn in 208 rounds as of Sep30 in Italy. They were €1.5 in all 2023. The new BeBeez Report

October 28, 2024
Next Post
Italy’s private debt & corporate finance weekly round-up. News from N-Sun Energy, Alantra Solar, ABN AMRO, BNP Paribas, Commerzbank, Rabobank, Ecoross, Intesa SanPaolo, Irem, and more

Italy's private debt & corporate finance weekly round-up. News from N-Sun Energy, Alantra Solar, ABN AMRO, BNP Paribas, Commerzbank, Rabobank, Ecoross, Intesa SanPaolo, Irem, and more

Seroba Announces Above Target Final Close of its Fund IV at €123M ($134M)

EdiBeez srl

C.so Italia 22 - 20122 - Milano
C.F. | P.IVA 09375120962
Aut. Trib. Milano n. 102
del 3 aprile 2013

COUNTRY

Italy
Iberia
France
UK&Ireland
Benelux
DACH
Scandinavia&Baltics

CATEGORY

Private Equity
Venture Capital
Private Debt
Distressed Assets
Real Estate
Fintech
Green

PREMIUM

ItaHUB
Legal
Tax
Trend
Report
Insight view

WHO WE ARE

About Us
Media Partnerships
Contact

INFORMATION

Privacy Policy
Terms&Conditions
Cookie Police

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • COUNTRY
    • ITALY
    • IBERIA
    • FRANCE
    • UK&IRELAND
    • BENELUX
    • DACH
    • SCANDINAVIA&BALTICS
  • PRIVATE EQUITY
  • VENTURE CAPITAL
  • PRIVATE DEBT
  • DISTRESSED ASSETS
  • REAL ESTATE
  • FINTECH
  • GREEN
  • PREMIUM
    • ItaHub
      • ItaHub Legal
      • ItaHub Tax
      • ItaHub Trend
    • REPORT
    • INSIGHT VIEW
    • Private Data
Subscribe
  • Login
  • Cart